News · Edaily·

Inventygen Lab Receives US Patent Registration for 12-Month Sustained Veterinary Castration Agent, Expanding Commercialization Discussions

Predicted impact: Low· Actual: +0.9% vs sector, volume 0.8× normal (5 trading days)

US patent registration for veterinary castration agent; commercial impact small and vague, no revenue figures given.

Comments

Sign in to comment

No comments yet. Start the conversation.

Comments are people's own views. Nothing here is financial advice.